Clinical use of the antiseptic polihexanide for genital tract infections

Skin Pharmacology and Physiology

Volumn 25, Issue 6, 2012, Pages 298-304

  Koban, I ^a   Bender, C P ^a   Assadian, O ^c   Kramer, A ^a   Hubner N O ^a,b  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antisepsis; Antiseptic; Bacterial vaginosis; Genital tract infection; Human papilloma virus; Polihexanide; Polyhexamethylene biguanide

Indexed keywords

ANTIINFECTIVE AGENT; CLINDAMYCIN; PLACEBO; POLY(HEXAMETHYLENEBIGUANIDE); POLYHEXANIDE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; CLINICAL EFFECTIVENESS; CONDYLOMA ACUMINATUM; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; GENITAL TRACT INFECTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; WART VIRUS;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; BIGUANIDES; CLINDAMYCIN; FEMALE; HUMANS; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCTIVE TRACT INFECTIONS;

EID: 84865061999     PISSN: 16605527     EISSN: 16605535     Source Type: Journal    
DOI: 10.1159/000340063     Document Type: Article

References (68)

1. Larsen B: Vaginal flora in health and disease. Clin Obstetr Gynecol 1993; 36: 107-121. (Pubitemid 23065136)
2. Pellati D, Mylonakis I, Bertoloni G, et al: Genital tract infections and infertility. Eur J Obstetr Gynecol Reprod Biol 2008; 140: 3-11.
3. Larsson PG, Carlsson B: Does pre- And postoperative metronidazole treatment lower vaginal cuff infection rate after abdominal hysterectomy among women with bacterial vaginosis? Inf Dis Obstetr Gynecol 2002; 10: 133-140. (Pubitemid 36019573)
4. Shopova E, Nikolov A, Dimitriv A: Link between the state of vaginal flora and the development of uroinfection during pregnancy (in Bulgarian). Akush Ginekol 2005; 44: 38- 39.
5. Tolosa JE: Chlorhexidine antisepsis to reduce neonatal mortality must be adopted globally. Ped Inf Dis J 2006; 25: 676-679. (Pubitemid 44162122)
6. Lamont RF, Taylor-Robinson D: The role of bacterial vaginosis, aerobic vaginitis, abnormal vaginal flora and the risk of preterm birth. BJOG 2010; 117: 119-120.
7. Andrade-Rocha FT: Ureaplasma urealyticum and Mycoplasma hominis in men attending for routine semen analysis: Prevalence, incidence by age and clinical settings, influence on sperm characteristics, relationship with the leukocyte count and clinical value. Urol Int 2003; 71: 377-381. (Pubitemid 37500530)
8. Cohen CR, Manhart LE, Bukusi EA, et al: Association between Mycoplasma genitalium and acute endometritis. Lancet 2002; 359: 765-766. (Pubitemid 34215080)
9. Svenstrup HF, Fedder J, Kristoffersen SE, et al: Mycoplasma genitalium, Chlamydia trachomatis, and tubal factor infertility - A prospective study. Fer Steril 2008; 90: 513-520.
10. Workowski KA, Berman SM, Douglas JM: Emerging antimicrobial resistance in Neisseria gonorrhoeae: Urgent need to strengthen prevention strategies. Ann Intern Med 2008; 148: 606-613. (Pubitemid 351669134)
11. Weidner W, Krause W, Ludwig M: Relevance of male accessory gland infection for subsequent fertility with special focus on prostatitis. Hum Reprod Update 1999; 5: 421-432. (Pubitemid 29512130)
12. Tian YH, Xiong JW, Hu L, et al: Candida albicans and filtrates interfere with human spermatozoal motility and alter the ultrastructure of spermatozoa: An in vitro study. Int J Androl 2007; 30: 421-429. (Pubitemid 47404272)
13. Tang YW, Himmelfarb E, Willis M, Stratton CW: Characterization of three Staphylococcus aureus isolates from a 17-year-old female who died of tampon-related toxic shock syndrome. J Clin Microbiol 2010; 48: 1974-1977.
14. Ellies E, Vallée F, Mari A, Silva S, Bauriaud R, Fourcade O, Genestal M: Toxic shock syndrome consecutive to the presence of vaginal tampon for menstruation regressive after early haemodynamic optimization and activated protein C infusion. Ann Fr Anesth Reanim 2009; 28: 91-95.
15. Parsonnet J, Hansmann MA, Delaney ML, Modern PA, Dubois AM, Wieland-Alter W, Wissemann KW, Wild JE, Jones MB, Seymour JL, Onderdonk AB: Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women. J Clin Microbiol 2005; 43: 4628- 4634. (Pubitemid 41298254)
16. Eschenbach DA, Hillier S, Critchlow C, et al: Diagnosis and clinical manifestations of bacterial vaginosis. Am J Obstetr Gynecol 1988; 158: 879-828.
17. Hillier S, Holmes KK: Bacterial Vaginosis. New York, McGraw-Hill, 1999.
18. Hoyme UB, Eschenbach DA: Bakterielle Vaginose. Dtsch Med Wochenschr 1985; 110: 349-352.
19. Harmanli OH, Cheng GY, Nyirjesy P, et al: Urinary tract infections in women with bacterial vaginosis. Obstetr Gynecol 2000; 95: 710-712. (Pubitemid 30210056)
20. Hillebrand L, Harmanli OH, Whiteman V, et al: Urinary tract infections in pregnant women with bacterial vaginosis. Am J Obstetr Gynecol 2002; 186: 916-917.
21. Sobel JD: Bacterial vaginosis. Annu Rev Med 2000; 51: 349-356. (Pubitemid 30216042)
22. Spinillo A, Capuzzo E, Gulminetti R, et al: Prevalence of and risk factors for fungal vaginitis caused by non-albicans species. Am J Obstet Gynecol 1997; 176: 138-141. (Pubitemid 127780762)
23. Wølner-Hanssen P, Krieger JN, Stevens CE, et al: Clinical manifestations of vaginal trichomoniasis. JAMA 1989; 261: 571-576. (Pubitemid 19033869)
24. Joesoef MR, Schmid GP, Hillier SL: Bacterial vaginosis: Review of treatment options and potential clinical indications for therapy. Clin Infect Dis 1999; 28(SUPPL1):S57-S65. (Pubitemid 29249961)
25. Colsky AS, Kirsner RS, Kerdel FA: Analysis of antibiotic susceptibilities of skin wound flora in hospitalized dermatology patients: The crisis of antibiotic resistance has come to the surface. Arch Dermatol 1998; 134: 1006- 1009. (Pubitemid 28385324)
26. Fischbach F, Petersen EE, Weissenbacher ER, et al: Efficacy of clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis. Obstetr Gynecol 1993; 82: 405-410. (Pubitemid 23251362)
27. Paavonen J, Mangioni C, Martin MA, et al: Vaginal clindamycin and oral metronidazole for bacterial vaginosis: A randomized trial. Obstetr Gynecol 2000; 96: 256-260. (Pubitemid 30447349)
28. Shubair M, Stanek R, White S, et al: Effects of chlorhexidine gluconate douche on normal vaginal flora. Gynecol Obstet Invest 1992; 34: 229-233. (Pubitemid 23023100)
29. Grassi TF, Camargo EA, Salvadori DMF, et al: DNA damage in multiple organs after exposure to chlorhexidine in Wistar rats. Int J Hyg Environ Health 2007; 210: 163-167. (Pubitemid 46187200)
30. Sonis ST, Clark WB, Shklar G: Chlorhexidine-induced lingual keratosis and dysplasia in rats. J Periodontol 1978; 49: 585-591. (Pubitemid 9079449)
31. Bassetti C, Kallenberger A: Influence of chlorhexidine rinsing on the healing of oral mucosa and osseous lesions. J Clin Periodontol 1980; 7: 443-456.
32. Paunio KU, Knuttila M, Mielitynen H: The effect of chlorhexidine gluconate on the formation of experimental granulation tisue. J Periodontol 1978; 49: 92-95. (Pubitemid 8318135)
33. Lee TH, Hu CC, Lee SS, et al: Cytotoxicity of chlorhexidine on human osteoblastic cells is related to intracellular glutathione levels. Int Endod J 2010; 43: 430-435.
34. Lessa FC, Aranha AM, Nogueira I, et al: Toxicity of chlorhexidine on odontoblast-like cells. J Appl Oral Sci 2010; 18: 50-58.
35. Gavlick WK, Davis PK: Gas chromatographic determination of p-chloroaniline in a chlorhexidine digluconate-containing alcohol foam surgical scrub product. J AOAC Int 1994; 77: 583-586.
36. Hübner NO, Kramer A: Review on the efficacy, safety and clinical applications of polihexanide, a modern wound antiseptic. Skin Pharmacol Physiol 2010; 23: 17-27.
37. Hübner NO, Siebert J, Kramer A: Octenidine dihydrochloride, a modern antiseptic for skin, mucous membranes and wounds. Skin Pharmacol Physiol 2010; 23: 244-258.
38. Kramer A, Roth B: Polihexanid; in Kramer A, Assadian O (eds): Wallhäussers Praxis der Sterilisation, Desinfektion, Antiseptik und Konservierung. Stuttgart, Thieme, 2008, pp 789-793.
39. Hansmann F, Kramer A, Ohgke H, et al: Polyhexamethylbiguanid (PHMB) as preoperative antiseptic for cataract surgery. Ophthalmologe 2004; 101: 377-383. (Pubitemid 38661255)
40. Hansmann F, Kramer A, Ohgke H, et al: Lavasept as an alternative to PVP-iodine as a preoperative antiseptic in ophthalmic surgery: Randomized, controlled, prospective double-blind trial. Ophthalmologe 2005; 102: 1043-1046.
41. Gerli SDR, Di Renzo GC: A new approach for the treatment of bacterial vaginosis: Use of polyhexamethylene biguanide - A prospective, randomized study. Eur Rev Med Pharmacol Sci 2003; 7: 127-130. (Pubitemid 38659935)
42. Müller G, Kramer A: Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. J Antimicrob Chemother 2008; 61: 1281-1287. (Pubitemid 351753595)
43. Kramer A, Daeschlein G, Kammerlander G, et al: Konsensusempfehlung zur Auswahl von Wirkstoffen für die Wundantiseptik. Hyg Med 2004; 29: 147-157.
44. Gabriel GJ, Som A, Madkour AE, Eren T, Tew GN: Infectious disease: Connecting innate immunity to biocidal polymers. Mater Sci Eng R Rep 2007; 57: 28-64. (Pubitemid 47042367)
45. Gilbert P, Moore LE: Cationic antiseptics: diversity of action under a common epithet. J Appl Microbiol 2005; 99: 703-715. (Pubitemid 41399812)
46. Ikeda T, Ledwith A, Bamford CH, et al: Interaction of a polymeric biguanide biocide with phospholipid membranes. Biochim Biophys Acta 1984; 769: 57-66.
47. Yasuda K, Ohmizo C, Katsu T: Potassium and tetraphenylphosphonium ion-selective electrodes for monitoring changes in the permeability of bacterial outer and cytoplasmic membranes. J Microbiol Methods 2003; 54: 111-115. (Pubitemid 36555801)
48. Ikeda T, Tazuke S, Watanabe M: Interaction of biologically active molecules with phospholipid membranes. 1. Fluorescence depolarization studies on the effect of polymeric biocide bearing biguanide groups in the main chain. Biochim Biophys Acta 1983; 735: 380-386.
49. Ikeda T, Tazuke S, Bamford C, et al: Spectroscopic studies on the interaction of polymeric in-chain biguanide biocide with phospholipid membranes as probed by 8-anilinonaphthalene-1-sulfonate. Bull Chem Soc Jpn 1985; 58: 705-709.
50. Rosin M, Welk A, Kocher T, et al: The effect of a polyhexamethylene biguanide mouthrinse compared to an essential oil rinse and a chlorhexidine rinse on bacterial counts and 4-day plaque regrowth. J Clin Periodontol 2002; 29: 392-399. (Pubitemid 41697825)
51. Gilbert P, Das JR, Jones MV, et al: Assessment of resistance towards biocides following the attachment of micro-organisms to, and growth on, surfaces. J Appl Microbiol 2001; 91: 248-254. (Pubitemid 32682047)
52. Hammann A, Huebner NO, Bender C, et al: Antiseptic efficacy and tolerance of tissuetolerable plasma compared with two wound antiseptics on artificially bacterially contaminated eyes from commercially slaughtered pigs. Skin Pharmacol Physiol 2010; 23: 328-332.
53. Müller G, Kramer A: Effect of selected, wound antiseptics on adult articular cartilage (bovine sesamoid bone) in the presence of Escherichia coli and Staphylococcus aureus. J Orthop Res 2005; 23: 127-133. (Pubitemid 40045086)
54. Koburger T, Hübner NO, Braun M, et al: Standardized comparison of antiseptic efficacy of triclosan, PVP-iodine, octenidine dihydrochloride, polyhexanide and chlorhexidine digluconate. J Antimicrob Chemother 2010; 65: 1712-1719.
55. Minozzi M, Gerli S, Di Renzo GC, et al: The efficacy and safety of a single dose of polyhexamethylene biguanide gynaecologic solution versus a seven-dose regimen of vaginal clindamycin cream in patients with bacterial vaginosis. Eur Rev Med Pharmacol Sci 2008; 12: 59-65. (Pubitemid 351425357)
56. Valluri S, Fleming TP, Laycock KA, et al: In vitro and in vivo effects of polyhexamethylene biguanide against herpes simplex virus infection. Cornea 1997; 16: 556-559. (Pubitemid 27381609)
57. Krebs FC, Miller SR, Ferguson ML, et al: Polybiguanides, particularly polyethylene hexamethylene biguanide, have activity against human immunodeficiency virus type 1. Biomed Pharmacother 2005; 59: 438- 445. (Pubitemid 41383837)
58. Fiscella RG, Moshifar M, Messick CR, et al: Polyhexamethylene biguanide (PHMB) in the treatment of experimental Fusarium keratomycosis. Cornea 1997; 16: 447-449. (Pubitemid 27282184)
59. Roth B, Baltzer K: Preliminary treatment of the recipient site and healing of open spongiosa transplant in post-traumatic osteitis. Helv Chir Acta 1989; 56: 571-572.
60. Roth B, Baltzer K: Preventive intraoperative irrigation in wound management with Lavasept: Report of experiences with 1,610 cases. Z Unfallchir Versicherungsmed 1990; 83: 224-226.
61. Marelli G, Papaleo E, Origoni M, et al: Polyhexamethylene biguanide for treatment of external genital warts: A prospective, doubleblind, randomized study. Eur Rev Med Pharmacol Sci 2005; 9: 369-372. (Pubitemid 43180327)
62. Kampf G, Hofer M, Wendt C: Efficacy of hand disinfectants against vancomycin-resistant enterococci in vitro. J Hosp Infect 1999; 42: 143-150. (Pubitemid 29273821)
63. Russell AD: Plasmids and bacterial resistance to biocides. J Appl Microbiol 1997; 83: 155-165. (Pubitemid 27329760)
64. Tattawasart U, Maillard JY, F, et al: Development of resistance to chlorhexidine diacetate and cetylpyridinium chloride in Pseudomonas stutzeri and changes in antibiotic susceptibility. J Hosp Infect 1999; 42: 219-229. (Pubitemid 29353738)
65. Yamamoto T, Tamura Y, Yokota T: Antiseptic and antibiotic resistance plasmid in Staphylococcus aureus that possesses ability to confer chlorhexidine and acrinol resistance. Antimicrob Agents Chemother 1988; 32: 932-935.
66. Lambert RJ, Joynson J, Forbes B: The relationships and susceptibilities of some industrial, laboratory and clinical isolates of Pseudomonas aeruginosa to some antibiotics and biocides. J Appl Microbiol 2001; 91: 972-984. (Pubitemid 33132064)
67. Moore LE, Ledder RG, Gilbert P, et al: In vitro study of the effect of cationic biocides on bacterial population dynamics and susceptibility. Appl Environ Microbiol 2008; 74: 4825-4834.
68. Koburger T, Müller G, Eisenbeiss W, et al: Microbicidal activity of polihexanide. GMS Krankenhaushyg Interdiszip 2007; 2:Doc44.